Abstracts

Citation

Kristin Baltrusaitis, Lauren Bergam, Musunga Tomu, Taguma Allen Matubu, Jim Aizire, Florence Nabwire, Taha Taha, Dhayendre Moodley, Gerhard Theron, Lee Fairlie, Kevin Knowles, Kathy George, Patrick Jean-Philippe, George Siberry, Mary Glenn Fowler, Lynda Stranix-Chibanda, IMPAACT P1084s Study Team. Changes in Bone Turnover Markers after Delivery in Breastfeeding Mothers with and without ART. Presented at: International Pediatric HIV Workshop.

Citation

Pearl Samson, M.S., Richard M. Rutstein, M.D., Terence Fenton, Ed.D., Jennifer J. Kiser, Pharm.D., Courtney V. Fletcher, Pharm.D., Steven M. Schnittman, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Elizabeth (Betsy) Smith, M.D., Bobbie L. Graham, B.S., Grace M. Aldrovandi, MD. Changes in cholesterol (CH) and triglyceride (TG) levels among pediatric patients treated with atazanavir (ATV), with/without ritonavir boosting (RTV), the 1020A NIH PACTG protocol. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.

Citation

Changes in Tenofovir Population Pharmacokinetics during Pregnancy.

Citation

Characteristics and Management of Highly Active Antiretroviral Treatment Failure among Children and Adolescents Perinatally Infected with HIV in the US. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.

Citation

Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Ruth E. Tuomala, M.D., Henry Pollack, M.D., David E. Shapiro, Ph.D., Sandra K. Burchett, M.D., M.S., Shiara Melissa Ortiz-Pujols, B.A., James McNamara, M.D. Characteristics of, and receipt of antiretroviral drug(s) during pregnancy among, HIV-infected women in the U.S.: PACTG 367. Presented at: 41st Infectious Diseases Society of America Annual Meeting.

Citation

Paige L. Williams, Ph.D., Betsy Kammerer, Ph.D., Grace Montepiedra, Ph.D., Sharon L. Nichols, Ph.D., Patricia Sirois, Ph.D., Deborah S. Storm, R.N.,Ph.D, John J. Farley, M.D., M.P.H., Kathleen Malee, Ph.D. Characterization of medication adherence in children and adolescents with HIV infection. Presented at: 12th Conference on Retroviruses and Opportunistic Infections.

Citation

Laura Heath, S. Conway, K. Nakamura, K. Semrau, Donald M. Thea, Louise Kuhn, James I. Mullins, Grace M. Aldrovandi, MD. Characterization of vertically transmitted subtype C HIV during acute infection. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Isabelle Roseto, Lori Silveria, Kaili Curtis, Jennifer Canniff, Adriana Weinberg, Christiana Smith. Characterizing Immune Activation in HIV-Exposed but Uninfected Infants in the First Year of Life. Presented at: CROI 2026.

Citation

Diana Gibb, M.D., M.Sc., MRCP, Ann J. Melvin, M.D., M.P.H., Alexandra Compagnucci, M.D., Ross E. McKinney, Jr., M.D., Gareth Tudor Williams, M.D., Sarah Walker, M.Sc., Ph.D., Lynda Harper, M.Sc., Janice Hodge, R.N., B.S., Christine Powell, M.A., Yacine Saidi, Ph.D., Alberto A. Ortiz, M.S., Mary Patricia Toye, R.N., M.S., Lynne M. Mofenson, M.D., F.A.A.P., Carlo Giaquinto, M.D., Michael Hughes, Ph.D. Choice of First-Line ART Regimen in PENTA 1: A Randomized Trial of Combination Antiretroviral Regimens and Treatment Switching Strategies in Antiretroviral Naive Children >/= 30 days and Presented at: XV International Conference on AIDS.

Citation

Coleen K. Cunningham, M.D., Joseph A. Church, M.D., Paul Palumbo, M.D., Prakash Sista, Ph.D., Michael Hughes, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Elaine Margaret Smith, M.D. Chronic subcutaneous T-20 in HIV-infected children: safety and antiviral activity.